Dr. Bedi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
Johns Hopkins University School of Medicine, Cancer Research Building II
1551 Orleans Street
Baltimore, MD 21231Phone+1 410-614-2793Fax+1 410-614-1411- Is this information wrong?
Education & Training
- Johns Hopkins UniversityFellowship, Hematology and Medical Oncology, 1990 - 1993
- Wayne State University School of MedicineResidency, Internal Medicine, 1987 - 1990
- All India Institute of Medical SciencesClass of 1985
Certifications & Licensure
- MD State Medical License 1990 - 2016
Publications & Presentations
PubMed
- 50 citationsImmune profiles in primary squamous cell carcinoma of the head and neck.Vassiliki Saloura, Evgeny Izumchenko, Zhixiang Zuo, Riyue Bao, Michael Korzinkin, Ivan V. Ozerov, Alex Zhavoronkov, David Sidransky, Atul Bedi, Mohammad O. Hoque, Hart...> ;Oral Oncology. 2019 Sep 1
- 221 citationsBifunctional immune checkpoint-targeted antibody-ligand traps that simultaneously disable TGFβ enhance the efficacy of cancer immunotherapyRajani Ravi, Kimberly A. Noonan, Vui Pham, Rishi Bedi, Alex Zhavoronkov, Ivan V. Ozerov, Eugene Makarev, Artem V. Artemov, Piotr T. Wysocki, Ranee Mehra, Sridhar Nimma...> ;Nature Communications. 2018 Feb 21
- 53 citationsSMAD4 Loss Is Associated with Cetuximab Resistance and Induction of MAPK/JNK Activation in Head and Neck Cancer CellsHiroyuki Ozawa, Ruchira Ranaweera, Evgeny Izumchenko, Eugene Makarev, Alex Zhavoronkov, Elana J. Fertig, Jason D. Howard, Ana Markovic, Atul Bedi, Rajani Ravi, Jimena ...> ;Clinical Cancer Research. 2017 Sep 1
- Join now to see all
Press Mentions
- Biocon Launches Bifunctional Antibody IO Subsidiary Bicara with $40 MillionMarch 15th, 2021
- New Cancer Drugs Enable Immune Cells to Fight CancerMarch 5th, 2018
- Johns Hopkins Researchers Invent New Technology for Cancer ImmunotherapyMarch 2nd, 2018
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: